Global linear accelerator market is segmented on the basis of preferred
method of utilizing the device, application and geography . Linear accelerator
is a device that destroys cancerous cells without affecting the surrounding
normal cells. Linear accelerator (LINAC) functions in a way that it accelerates
electrons through a linear tube with high speeds resulting in x-rays emission.
Higher x-rays generate large electronic potential which is useful in longer
accelerating cavity resulting in greater efficiency for destruction of tumors.
Linear accelerator (LINAC) can be utilized on any part of human body with
greater efficiency for brain tumor applications.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/linear-accelerator-market
The linear accelerator market is primarily driven by a few key factors
such as rising prevalence of cancers, efficiency of linear accelerator to
deliver high doses of radiation to the tumor with limited damage to the
surrounding normal tissues or organs and rising adaptation of radiotherapy
devices and procedures for treatment of various tumors.
In addition to this the major advantage of linear accelerator device is
that the therapy is painless compared to normal radiation therapies. The linear
accelerator market however faces various challenges such as limited data
availability pertaining to the outcome of the device usage, and linear
accelerator device is unsupported by evidence based outcome studies. Also, shortage
of skilled personnel to prescribe appropriate dosage and sessions is observed
in the linear accelerator market. Various healthcare reforms which are
unfavorable to the technology also create hindrance in linear accelerator
market.
On the basis of preferred method of utilizing the device, the linear
accelerator market is segmented into dedicated linear accelerator,
non-dedicated linear accelerator and so on. On the basis of application, the
linear accelerator market is segmented into breast cancer, prostate cancer,
lung cancer, head & neck cancers, and colorectal cancers and so on.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/linear-accelerator-market/request-sample
On the basis of geography, the linear accelerator industry is segmented
into Latin America, Europe, Asia Pacific, North America and Middle East &
Africa. North America holds a leading position in the linear accelerator market
due to the growing incidence of tumors and cancers, growing advancement of
healthcare infrastructure, increasing per-capita income.
The major driving factors which have driven the growth of the linear
accelerator market in this region is constantly increasing regulatory scenario
monitored by various organizations for the safety and health issues,
technological advancement in finding new techniques, rise in funding in public
and private sector.
Following North America, European countries are also anticipated to show
steady growth in the linear accelerator industry. Asia Pacific region has
improved its healthcare scenario by showing numerous growth opportunities
supporting the current healthcare reforms, launching novel diagnostic products
which are anticipated to increase the adoption of these diagnostic tests
throughout the continent resulting to emerge as a fastest growing region in
linear accelerator industry. The key players in the linear accelerator industry
include Varian, Accuracy, Elekta Group of Companies manufacturing linear
accelerator products such as Versa HD, Philips, GE Healthcare, Toshiba,
Mitsubishi Heavy Industries (MHI), Shinva, Neusoft, Top Grade Healthcare,
Hamming, Huiheng Medical, Infinity/ Axesse, Synergy/S, Synergy Platform,
Siemens Healthcare manufacturing linear accelerator products such as Artiste,
Oncor (Impression, Expression & Avante Garde), Primus K, Primus M, Accuracy
Incorporated and Brainlab AG.
Comments
Post a Comment